Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients

Table 1

Baseline characteristics of the 109 HCV-1 rs12979860 CC patients.

Patients	Overall (𝑁=109)
Males	60 (55%)
Age, years (mean)	53 (range 24–70)
Weight, kg (mean)	68.4 (41–110)
BMI > 25	39 (36%)
Liver fibrosis stage (Ishak)
S 0–2	50 (46%)
S 3-4	29 (26%)
S 5-6	30 (28%)
HCV genotype
1b	94 (86%)
1a	15 (14%)
Baseline serum HCV-RNA
>0.6 × 10^6 IU/mL	69 (63%)
PegIFN type
alfa2a	50 (46%)
alfa2b	59 (54%)